Stuart has worked in senior positions within the health sector since 1998. He has been in the international pharmaceutical industry since 2002, founding and establishing Panacea in 2008. His experience in the pharma industry has primarily been in the development and supply chain phases, and his entire career has been immersed in service provision.
Stuart is committed to establishing excellent, honest, and mutually-rewarding partnerships with Panacea’s clients, and his service sector background ensures that this is a natural element of Panacea’s culture.
Having set up and run several successful businesses, Stuart gives Panacea the grounding to grow confidently as a long-term, sustainable, partner of choice for the best companies in the industry.
Operations Director & Head of Pharmacovigilance
Anne has been working in the pharmaceutical industry since 1996.
After graduating with a BSc (Hons) in Biochemistry, Anne went on to gain a Postgraduate Diploma in Pharmacovigilance while working at Pharmacia & Upjohn in 1999. Since then she has built up a wealth of experience relating to clinical trials and post‐marketing pharmacovigilance, as well as working within regulatory affairs and medical information departments and being heavily involved in various product launches.
Anne joined Panacea in 2010 and is an expert at guiding clients through the outsourcing process.
She has participated in numerous audits and authority inspections during her career (including by the MHRA and FDA), and has successfully led many Panacea clients through the process.
Dan began his career in pharmacovigilance in 2005 and has since held a number of senior pharmacovigilance operational roles as well as acting as EU Qualified Person for Pharmacovigilance.
Dan has been involved in establishing and developing pharmacovigilance systems for Marketing Authorisation Holders including responsibility for leading teams in all areas of pharmacovigilance.
Since 2015, Dan has specialised in Quality Assurance and auditing, conducting multiple pharmacovigilance audits globally of various stakeholders including affiliates, license partners, vendors and process audits as part of a large innovator company and a global Quality Assurance Consultancy.
Dan holds a BSc(Hons) degree in Pharmacology and a Postgraduate Diploma in Pharmacovigilance.
Director of QPPV Services
Sally started her career as a midwife before switching to the pharmaceutical industry in 2002. After initially putting her medical background to good use in patient support roles, she transitioned over to pharmacovigilance in 2005.
Before joining Panacea in August 2011 as an EU QPPV, Sally worked for two large global innovator pharmaceutical companies and a UK generics company, where she gained valuable experience in clinical trials, post-approval pharmacovigilance and medical device vigilance.
Sally has experience on both sides of the auditing table as she has conducted audits on behalf of Panacea, and has also successfully led Panacea clients through audits and inspections in her role as an EU QPPV.
Sally is currently head of Panacea’s QPPV Office offering global QPPV services, and she is also responsible for managing our local pharmacovigilance contacts at a national level where required.
Liezl is a GMC-registered medical doctor and is Panacea’s in-house Safety Physician.
Since joining the Panacea team in 2010, Liezl has worked closely with numerous Panacea clients and has amassed a huge amount of experience and knowledge covering a wide variety of products and therapeutic areas.
Liezl is responsible for the medical review of our clients’ pharmacovigilance documents and processes, and she is committed to consistently providing a sound medical opinion.
Liezl's combination of experience, knowledge and professionalism mean that Panacea clients can be absolutely confident that all safety aspects are covered.
Commercial Development Manager
Dan is a registered pharmacist with 12 years’ experience working within pharmaceutical Regulatory Affairs and Product Labelling for large generic companies.
Dan joined Panacea as Commercial Development Manager in 2018 and his industry knowledge and technical understanding enable him to tailor our service offerings to meet the specific needs of each individual client.